If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 41 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Esophagectomy Medicine & Life Sciences
Gastrectomy Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 5060 Citations
  • 34 h-Index
  • 335 Article
  • 27 Review article
  • 7 Comment/debate
  • 1 Chapter
1 Citation (Scopus)

Amide proton transfer imaging to predict tumor response to neoadjuvant chemotherapy in locally advanced rectal cancer

Nishie, A., Asayama, Y., Ishigami, K., ushijima, Y., Takayama, Y., Okamoto, D., fujita, N., Tsurumaru, D., Togao, O., Sagiyama, K., Manabe, T., Oki, E., kubo, Y., Hida, T., Hirahashi-Fujiwara, M., Keupp, J. & Honda, H., Jan 1 2019, In : Journal of Gastroenterology and Hepatology (Australia). 34, 1, p. 140-146 7 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
Amides
Protons
Drug Therapy
Neoplasms

A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer

Bando, H., Kagawa, Y., Kato, T., Akagi, K., Denda, T., Nishina, T., Komatsu, Y., Oki, E., Kudo, T., Kumamoto, H., Yamanaka, T. & Yoshino, T., Jan 1 2019, In : British journal of cancer.

Research output: Contribution to journalArticle

Multicenter Studies
Colorectal Neoplasms
Prospective Studies
Mutation
Neoplasm Metastasis

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)

Kato, K., Satoh, T., Muro, K., Yoshikawa, T., Tamura, T., Hamamoto, Y., Chin, K., Minashi, K., Tsuda, M., Yamaguchi, K., Machida, N., Esaki, T., Goto, M., Komatsu, Y., Nakajima, T. E., Sugimoto, N., Yoshida, K., Oki, E., Nishina, T., Tsuji, A. & 11 othersFujii, H., Kunieda, K., Saitoh, S., Omuro, Y., Azuma, M., Iwamoto, Y., Taku, K., Fushida, S., Chen, L. T., Kang, Y. K. & Boku, N., Mar 15 2019, In : Gastric Cancer. 22, 2, p. 344-354 11 p.

Research output: Contribution to journalArticle

Open Access
Esophageal Neoplasms
Stomach
Placebos
Drug Therapy
Survival
1 Citation (Scopus)

C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer

Kudou, K., Saeki, H., Nakashima, Y., Kamori, T., Kawazoe, T., Haruta, Y., Fujimoto, Y., Matsuoka, H., Sasaki, S., Jogo, T., Hirose, K., Hu, Q., Tsuda, Y., Kimura, K., Andou, K., Oki, E., Ikeda, T. & Maehara, Y., Feb 1 2019, In : Journal of Gastroenterology and Hepatology (Australia). 34, 2, p. 355-363 9 p.

Research output: Contribution to journalReview article

Esophagogastric Junction
C-Reactive Protein
Stomach Neoplasms
Albumins
Adenocarcinoma

Effect of lateral lymph node dissection for mid and low rectal cancer: An ad-hoc analysis of the ACTS-RC (JFMC35-C1) randomized clinical trial

Oki, E., Shimokawa, M., Andou, K., Murata, A., Takahashi, T., Maeda, K., Kusumoto, T., Munemoto, Y., Nakanishi, R., Nakashima, Y., Saeki, H. & Maehara, Y., Mar 1 2019, In : Surgery (United States). 165, 3, p. 586-592 7 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
Lymph Node Excision
Randomized Controlled Trials
Recurrence
Adjuvant Chemotherapy